These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33489909)

  • 21. BolA family member 2 enhances cell proliferation and predicts a poor prognosis in hepatocellular carcinoma with tumor hemorrhage.
    Luo J; Wang D; Zhang S; Hu K; Wu H; Li J; Wang Z; Tao Y
    J Cancer; 2019; 10(18):4293-4304. PubMed ID: 31413749
    [No Abstract]   [Full Text] [Related]  

  • 22. Transforming growth factor-beta1 and CD105 promote the migration of hepatocellular carcinoma-derived endothelium.
    Benetti A; Berenzi A; Gambarotti M; Garrafa E; Gelati M; Dessy E; Portolani N; Piardi T; Giulini SM; Caruso A; Invernici G; Parati EA; Nicosia R; Alessandri G
    Cancer Res; 2008 Oct; 68(20):8626-34. PubMed ID: 18922939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
    Jong HS; Lee HS; Kim TY; Im YH; Park JW; Kim NK; Bang YJ
    Biochem Biophys Res Commun; 2002 Mar; 292(2):383-9. PubMed ID: 11906173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High TGF-β1 expression predicts poor disease prognosis in hepatocellular carcinoma patients.
    Peng L; Yuan XQ; Zhang CY; Ye F; Zhou HF; Li WL; Liu ZY; Zhang YQ; Pan X; Li GC
    Oncotarget; 2017 May; 8(21):34387-34397. PubMed ID: 28415739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells.
    Li Q; Liu G; Shao D; Wang J; Yuan H; Chen T; Zhai R; Ni W; Tai G
    Int J Biochem Cell Biol; 2015 Feb; 59():116-25. PubMed ID: 25526895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
    Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APOB is a potential prognostic biomarker in hepatocellular carcinoma.
    Lin Z; Ji X; Tian N; Gan Y; Ke L
    Discov Oncol; 2024 Feb; 15(1):28. PubMed ID: 38310202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic biomarker MITD1 and its correlation with immune infiltrates in hepatocellular carcinoma (HCC).
    Shen H; Wang Z; Ren S; Wang W; Duan L; Zhu D; Zhang C; Duan Y
    Int Immunopharmacol; 2020 Apr; 81():106222. PubMed ID: 32007795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrative Analysis of Metallothioneins Identifies MT1H as Candidate Prognostic Biomarker in Hepatocellular Carcinoma.
    Zhang F; Guo S; Zhong W; Huang K; Liu Y
    Front Mol Biosci; 2021; 8():672416. PubMed ID: 34676244
    [No Abstract]   [Full Text] [Related]  

  • 32. Transforming Growth Factor β is a Poor Prognostic Factor and Inhibits the Favorable Prognostic Value of CD8+ CTL in Human Hepatocellular Carcinoma.
    Huang CY; Wang H; Liao W; Han F; Li YQ; Chen SW; Lao XM
    J Immunother; 2017 Jun; 40(5):175-186. PubMed ID: 28394813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ITGBL1 promotes cell migration and invasion through stimulating the TGF-β signalling pathway in hepatocellular carcinoma.
    Huang W; Yu D; Wang M; Han Y; Lin J; Wei D; Cai J; Li B; Chen P; Zhang X
    Cell Prolif; 2020 Jul; 53(7):e12836. PubMed ID: 32537856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up-regulated expression of phospholipase C, β1 is associated with tumor cell proliferation and poor prognosis in hepatocellular carcinoma.
    Li J; Zhao X; Wang D; He W; Zhang S; Cao W; Huang Y; Wang L; Zhou S; Luo K
    Onco Targets Ther; 2016; 9():1697-706. PubMed ID: 27051304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bioinformatics analysis and significance of expression of CC chemokine ligand 23 (CCL23) in hepatocellular carcinoma].
    Lu J; Yang Y; Yu P; Tao H; Lu X; Wang L; Liu D; Chen Y; Chen C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Oct; 35(10):903-909. PubMed ID: 31814567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer.
    Wang LT; Zeng QL; Jiang SL; Chen ZY; Wang XL; Li L; Li X
    Front Oncol; 2022; 12():987481. PubMed ID: 36425563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PRELP has prognostic value and regulates cell proliferation and migration in hepatocellular carcinoma.
    Hong R; Gu J; Niu G; Hu Z; Zhang X; Song T; Han S; Hong L; Ke C
    J Cancer; 2020; 11(21):6376-6389. PubMed ID: 33033521
    [No Abstract]   [Full Text] [Related]  

  • 38. POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1.
    Wang B; Xu X; Yang Z; Zhang L; Liu Y; Ma A; Xu G; Tang M; Jing T; Wu L; Liu Y
    EBioMedicine; 2019 Mar; 41():320-332. PubMed ID: 30745168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pituitary tumor transforming gene 1 (PTTG1) is highly expressed and associated with poor prognosis in patients with hepatocellular carcinoma].
    Tao H; Yang Y; Chen J; Lu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Apr; 36(4):337-343. PubMed ID: 32519672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of STX6 as a prognostic factor associated with immune infiltration in hepatocellular carcinoma.
    Zhang Y; Li L; Tu Y; Feng Z; Li Y; Xiong J
    Oncol Lett; 2022 Oct; 24(4):371. PubMed ID: 36238841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.